Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

848
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
848
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

908
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
908
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

1.7K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.7K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

768
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
768

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transoral neuromuscular electrical stimulation therapy adherence and intensity levels in veterans with mild OSA.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Validation of non-contact sensor quantification of heart rate and respiratory rate dynamics using real-world pretraining and label-efficient fine-tuning on polysomnograms.

medRxiv : the preprint server for health sciences·2026
Same author

Nocturnal Respiratory Rate and Variability Predict Long-term Mortality in Stable Outpatients with Cardiovascular Disease.

medRxiv : the preprint server for health sciences·2026
Same author

Cognitive recovery after critical illness: comparing English and Spanish-speaking survivors.

Critical care (London, England)·2026
Same author

Correction: Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Challenges for predicting oxygen response in OSA.

American journal of respiratory and critical care medicine·2026

Related Experiment Video

Updated: Jan 14, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.1K

Opioids and Respiratory Related Consequences.

Jeremy E Orr1, Deanna Hill1, Robert L Owens1

  • 1Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.

Sleep Medicine Clinics
|October 24, 2025
PubMed
Summary

Opioids, used for pain, can dangerously slow breathing and impair gas exchange. Chronic use may lead to sleep apnea, requiring careful monitoring and respiratory support to manage these risks.

Keywords:
CO2 response suppressionCentral sleep apneaNaloxoneObstructive sleep apneaOpioid-induced respiratory depressionOpioidsSleep-disordered breathing

More Related Videos

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

7.0K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.4K

Related Experiment Videos

Last Updated: Jan 14, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.1K
In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

7.0K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.4K

Area of Science:

  • Pharmacology
  • Respiratory Medicine
  • Sleep Medicine

Background:

  • Opioids are essential for pain management but carry significant respiratory risks.
  • Opioid-induced respiratory depression can impair gas exchange, posing life-threatening risks.
  • Chronic opioid use is linked to central sleep apnea and complicates obstructive sleep apnea management.

Purpose of the Study:

  • To summarize the respiratory effects of opioids.
  • To highlight the risks associated with opioid use in acute and chronic pain.
  • To discuss strategies for mitigating opioid-related respiratory complications.

Main Methods:

  • Literature review of opioid pharmacology and respiratory effects.
  • Analysis of clinical implications in hospital and chronic use settings.
  • Synthesis of current management strategies for opioid-induced respiratory issues.

Main Results:

  • Opioids suppress respiratory rate and the ventilatory response to CO2.
  • Chronic opioid use can cause central sleep apnea and worsen existing sleep-disordered breathing.
  • Significant impairment of gas exchange can occur, especially in hospital settings.

Conclusions:

  • Opioid-induced respiratory depression is a serious adverse effect requiring vigilant management.
  • Strategies include dose limitation, close monitoring, and respiratory support such as non-invasive ventilation.
  • Understanding and mitigating these respiratory risks are crucial for patient safety during opioid therapy.